BRIEF published on 08/06/2026 at 18:20, 10 days 11 hours ago BIOSYNEX SA victim of a cyberattack Security Data Cyberattack Health BIOSYNEX
BRIEF published on 08/06/2026 at 18:20, 10 days 11 hours ago BIOSYNEX SA victime d'une cyberattaque Santé Sécurité Données BIOSYNEX Cyberattaque
PRESS RELEASE published on 08/06/2026 at 18:15, 10 days 11 hours ago BIOSYNEX SA: Cyberattaque BIOSYNEX SA annonce avoir été victime d'une cyberattaque, prenant des mesures pour limiter l'impact et renforcer la sécurité. Aucune conséquence sur l'opérationnel. Enquête en cours Enquête Sécurité Cyberattaque BIOSYNEX SA Laboratoire
BRIEF published on 07/22/2026 at 18:05, 25 days 11 hours ago Chiffre d'affaires semestriel de BIOSYNEX en baisse Chiffre D'affaires BIOSYNEX Division Pharmacie Division Diagnostic Rééchelonnement De La Dette
BRIEF published on 07/22/2026 at 18:05, 25 days 11 hours ago BIOSYNEX's half-year revenue is down Revenue BIOSYNEX Pharmacy Division Diagnostic Division Debt Rescheduling
PRESS RELEASE published on 07/22/2026 at 18:00, 25 days 11 hours ago BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2026 : 44,1 M€ - PERSPECTIVES Biosynex SA annonce un chiffre d'affaires de 44,1 M€ au 1er semestre 2026 avec des perspectives de rééchelonnement de dette et nouveaux marchés Chiffre D'affaires Perspectives BIOSYNEX SA 1er Semestre 2026 Rééchelonnement Dette
BRIEF published on 06/11/2026 at 07:05, 2 months 5 days ago Biosynex finalise la cession de son activité de biologie moléculaire Cession Restructuration BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 2 months 5 days ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 2 months 5 days ago Biosynex cède son activité de biologie moléculaire Cession Croissance Stratégique BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 2 months 5 days ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
Published on 08/15/2026 at 00:15, 2 days 5 hours ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 2 days 5 hours ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:00, 2 days 6 hours ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/17/2026 at 02:00, 3 hours 28 minutes ago Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline
Published on 08/16/2026 at 19:40, 9 hours 47 minutes ago APIC delivers 55% EBITDA growth in the first half of 2026, reaching USD 44 million
Published on 08/16/2026 at 13:40, 15 hours 47 minutes ago Ajax says goodbye to Godts with a classy message in Paris: THE FUTURE BELONGS TO YOUNG GODTS
Published on 08/16/2026 at 09:45, 19 hours 42 minutes ago Ragnarok Zero: Global Set to Officially Launch on August 18
Published on 08/16/2026 at 06:15, 23 hours 12 minutes ago GARVEE met en avant les essentiels pour la maison et le jardin à l’approche de la transition entre la fin de l’été et le début de l’automne
Published on 08/13/2026 at 18:00, 3 days 11 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 5 days 11 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 5 days 11 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 6 days 11 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 6 days 11 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
